InsurTech Series B Investors & VC Firms
127 firms in this list, with a median first check of $1M. 38 of them lead rounds. Generated from verified public data and updated continuously.
Figure 8 Investments
Western North CarolinaSeed–Series B$50K – $500K
3 people
Meridian Street Capital
New YorkPre-Seed–Series B$100K – $5M
3 people
VIEWPOINT VENTURES
New YorkSeed–Series B
10 people
MDI Ventures
JakartaPre-Seed–Growth$500K – $75M
10 people
500 Startups Vietnam
Palo AltoPre-Seed–Growth$25K – $20M
8 people
Tekton Ventures
San FranciscoPre-Seed–Series C$100K – $1M
6 people
Nyca Partners
New YorkSeed–Growth
7 people
Sandalphon Capital
ChicagoPre-Seed–Series B$100K – $2M
3 people
BICECORP Ventures
SantiagoPre-Seed–Growth
10 people
MAIF Avenir
ParisSeed–Late Stage$10.8M
7 people
Inclusion Japan
Pre-Seed–Growth
Truffle Capital
ParisSeed–Growth$5M – $15M
5 people
Tauros Capital
ViennaSeries A–Growth$2.2M
3 people
Lingfeng Capital
BeijingSeed–Series B$1.7M – $45M
5 people
Opera Tech Ventures
ParisSeries A–Series C$3.2M – $16M
5 people
Juniper Ventures Management, Llc
San FranciscoPre-Seed–Growth
2 people
BOV Capital
ColomboSeed–Growth$100K
4 people
Second Century Ventures
ChicagoSeed–Growth
9 people
Companion Fund
New YorkPre-Seed–Growth
Applied Real Intelligence (A.R.I.)
Los AngelesSeries A–Late Stage$30M
6 people
Champel Capital
JerusalemSeed–Late Stage
5 people
Optimist Ventures
New YorkPre-Seed–Late Stage
4 people
Britam
NairobiSeed–Growth
11 people
INP Capital
VancouverSeed–Late Stage
5 people
Related lists
Series B Investors & VC Firms (4000)Series B Investors & VC Firms in United States (1566)SaaS Series B Investors & VC Firms (1287)Enterprise Software Series B Investors & VC Firms (1212)Series B Investors & VC Firms in Global (1187)Healthtech Series B Investors & VC Firms (1179)Fintech Series B Investors & VC Firms (1113)AI & Machine Learning Series B Investors & VC Firms (1081)Series B Investors & VC Firms in Europe (923)Consumer Series B Investors & VC Firms (890)
Data sourced from public filings and firms' own websites — see our methodology.










































